We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeks to Improve Cancer Therapies, Accelerate Drug Approvals
FDA Seeks to Improve Cancer Therapies, Accelerate Drug Approvals
February 17, 2006
The FDA, NIH and the Centers for Medicare & Medicaid Services (CMS) have launched an initiative that aims to develop personalized cancer treatments and accelerate cancer drug approvals through the use of biomarkers.